PL99025B1 - Sposob wytwarzania nowych aryloksyaminobutanoli,ich stereoizomerow i ich nietoksycznych soli addycyjnych z kwasami - Google Patents

Sposob wytwarzania nowych aryloksyaminobutanoli,ich stereoizomerow i ich nietoksycznych soli addycyjnych z kwasami Download PDF

Info

Publication number
PL99025B1
PL99025B1 PL1975193962A PL19396275A PL99025B1 PL 99025 B1 PL99025 B1 PL 99025B1 PL 1975193962 A PL1975193962 A PL 1975193962A PL 19396275 A PL19396275 A PL 19396275A PL 99025 B1 PL99025 B1 PL 99025B1
Authority
PL
Poland
Prior art keywords
hydroxy
stereoisomers
acids
aryloxyamin
butanols
Prior art date
Application number
PL1975193962A
Other languages
English (en)
Polish (pl)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL99025B1 publication Critical patent/PL99025B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/34—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/52—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups or amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL1975193962A 1974-02-20 1975-02-19 Sposob wytwarzania nowych aryloksyaminobutanoli,ich stereoizomerow i ich nietoksycznych soli addycyjnych z kwasami PL99025B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUCI1449A HU169464B (en, 2012) 1974-02-20 1974-02-20

Publications (1)

Publication Number Publication Date
PL99025B1 true PL99025B1 (pl) 1978-06-30

Family

ID=10994508

Family Applications (2)

Application Number Title Priority Date Filing Date
PL1975193962A PL99025B1 (pl) 1974-02-20 1975-02-19 Sposob wytwarzania nowych aryloksyaminobutanoli,ich stereoizomerow i ich nietoksycznych soli addycyjnych z kwasami
PL1975178154A PL99023B1 (pl) 1974-02-20 1975-02-19 Sposob wytwarzania nowych aryloksyaminobutanoli,ich stereoizomerow i ich nietoksycznych soli addycyjnych z kwasami

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL1975178154A PL99023B1 (pl) 1974-02-20 1975-02-19 Sposob wytwarzania nowych aryloksyaminobutanoli,ich stereoizomerow i ich nietoksycznych soli addycyjnych z kwasami

Country Status (22)

Country Link
JP (1) JPS5929063B2 (en, 2012)
AT (1) AT339281B (en, 2012)
BE (1) BE825745A (en, 2012)
BG (2) BG26366A3 (en, 2012)
CA (1) CA1074338A (en, 2012)
CH (1) CH619684A5 (en, 2012)
CS (1) CS199578B2 (en, 2012)
DD (1) DD119414A5 (en, 2012)
DE (1) DE2506355C2 (en, 2012)
DK (1) DK141935B (en, 2012)
ES (2) ES434784A1 (en, 2012)
FI (1) FI61304C (en, 2012)
FR (1) FR2261001B1 (en, 2012)
GB (1) GB1457086A (en, 2012)
HU (1) HU169464B (en, 2012)
IL (1) IL46634A (en, 2012)
NL (1) NL182698C (en, 2012)
NO (1) NO141754C (en, 2012)
PL (2) PL99025B1 (en, 2012)
SE (1) SE433935B (en, 2012)
SU (1) SU1025327A3 (en, 2012)
YU (2) YU36916B (en, 2012)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL48309A (en) * 1974-10-25 1980-01-31 Robins Co Inc A H 1-aryloxy-4-amino-2-butanols and pharmaceutical compositions containing them
EP0097000B1 (en) * 1982-06-10 1987-09-09 Beecham Wuelfing GmbH & Co KG Amine derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE368197B (en, 2012) * 1968-11-18 1974-06-24 Pfizer
GB1245148A (en) * 1968-11-18 1971-09-08 Pfizer Ltd Propanolamine derivatives
SE384853B (sv) * 1972-04-04 1976-05-24 Haessle Ab Forfarande for framstellning av nya aminer
AT305245B (de) * 1969-09-24 1973-02-12 Ici Ltd Verfahren zur Herstellung von neuen substituierten 1-Phenoxy-2-hydroxy-3-alkylaminopropanen und von deren Säureadditionssalzen

Also Published As

Publication number Publication date
ATA114075A (de) 1977-02-15
JPS5929063B2 (ja) 1984-07-18
CS199578B2 (en) 1980-07-31
BG26367A4 (bg) 1979-03-15
YU37375A (en) 1982-06-18
CA1074338A (en) 1980-03-25
DK141935C (en, 2012) 1980-12-08
AT339281B (de) 1977-10-10
DE2506355A1 (de) 1975-08-21
SE433935B (sv) 1984-06-25
BG26366A3 (bg) 1979-03-15
IL46634A (en) 1979-01-31
GB1457086A (en) 1976-12-01
FI750443A7 (en, 2012) 1975-08-21
HU169464B (en, 2012) 1976-11-28
NL7501951A (nl) 1975-08-22
FR2261001B1 (en, 2012) 1978-07-21
JPS50117728A (en, 2012) 1975-09-16
NO750566L (en, 2012) 1975-08-21
NO141754B (no) 1980-01-28
YU167681A (en) 1983-04-27
SU1025327A3 (ru) 1983-06-23
NL182698C (nl) 1988-05-02
ES453326A1 (es) 1977-11-16
DK60875A (en, 2012) 1975-10-20
IL46634A0 (en) 1975-04-25
YU36916B (en) 1984-08-31
DE2506355C2 (de) 1983-10-06
FI61304C (fi) 1982-07-12
FR2261001A1 (en, 2012) 1975-09-12
PL99023B1 (pl) 1978-06-30
ES434784A1 (es) 1977-03-16
NO141754C (no) 1980-05-07
CH619684A5 (en) 1980-10-15
BE825745A (fr) 1975-06-16
YU37116B (en) 1984-08-31
DD119414A5 (en, 2012) 1976-04-20
FI61304B (fi) 1982-03-31
DK141935B (da) 1980-07-21
SE7501801L (en, 2012) 1975-08-21

Similar Documents

Publication Publication Date Title
FI93214C (fi) Menetelmä ja välituote lääkeaineina käyttökelpoisten 0-(3-amino-2-hydroksipropyyli)-hydroksi-imiinihappohalidien valmistamiseksi
AT363096B (de) Verfahren zur herstellung von neuen phthalazinderivaten und deren salzen
CA1190224A (en) Derivatives of 1,2-diamino-cyclobutene-3,4-dione as potent histamine h.sub.2-antagonists
BURGER et al. ANALGESIC STUDIES. β-ETHYL AND β-ISOPROPYLAMINE DERIVATIVES OF PYRIDINE AND THIAZOLE1
US4081447A (en) 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
PL113879B1 (en) Process for preparing novel racemic or optically active1-aryloxy-2-hydroxy-3-alkylenaminopropanes
PL110654B1 (en) Method of producing new ethers of hydroxy-benzodiheterocyclic compounds
EP0004532A1 (de) 1-Aryloxy-3-nitratoalkylamino-2-propanole, Verfahren zu ihrer Herstellung und ihre pharmazeutischen Zubereitungen
DE1964423A1 (de) Verfahren zur Herstellung von aromatischen Aethern
DD295353A5 (de) Verfahren zur herstellung von benzonitrilderivaten
CH630344A5 (en) Process for the preparation of novel O-(3-amino-2-hydroxypropyl)-amidoxime derivatives.
DE68916979T2 (de) Alkylen-diamine.
CZ20022006A3 (cs) Substituované norbornylaminové deriváty, způsob jejich přípravy a jejich použití jako léčiva nebo diagnostika
DE2434951A1 (de) 3-substituierte diphenylhydantoine
US3381013A (en) Heterocyclicamino ethers of benzylphenols
PL99025B1 (pl) Sposob wytwarzania nowych aryloksyaminobutanoli,ich stereoizomerow i ich nietoksycznych soli addycyjnych z kwasami
CH649547A5 (de) 1,2,4-oxadiazolin-5-on-derivate, ihre herstellung, sowie pharmazeutische mittel die solche derivate enthalten.
EP0011747B1 (de) Aminopropanolderivate des 6-Hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepin-2-ons, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
DK158944B (da) Analogifremgangsmaade til fremstilling af substituerede methylimidazolforbindelser
DE2300018C2 (de) 1-[N-Methyl-N-(β-phenyläthyl)-3-aminopropyl]- benzimidazol-Abkömmlinge
JPS59116269A (ja) イソカルボスチリル誘導体
DE2923817B1 (de) (3-Alkylamino-2-hydroxypropoxy)-furan-2-carbonsaeureanilide und deren physiologisch vertraegliche Saeureadditionssalze und Verfahren zu deren Herstellung sowie Arzneimittel mit einem Gehalt dieser Verbindungen
PL90714B1 (en, 2012)
GB2178035A (en) Novel benzamides and their preparation and therapeutic application
NO300892B1 (no) Opplöselige salter av 4-amino-2-(4,4-dimetyl-imidazolidin-2-on-1-yl)-pyrimidin-5-karboksylsyre-£N-metyl-N-(3-trifluormetyl-fenyl)-amid|, utgangsprodukter og forbindelsenes anvendelse som legemiddel